Sessa Capital (Master) L.P. insider trades

Open-market stock purchases and sales by Sessa Capital (Master) L.P., Director at SAB Biotherapeutics, Inc, from SEC Form 4 filings since Jan 18, 2023.

Recent trades

No open-market trades in the last 12 months.

Companies traded

SABS SAB Biotherapeutics, Inc: other filings, last Sep 29, 2025
PRVB Provention Bio, Inc: 2 sales, last Apr 27, 2023

Get free alerts when Sessa Capital (Master) L.P. files a new trade →